4 months Supernus Pharmaceuticals (NASDAQ:SUPN) Reaches New 12-Month High – Time to Buy? MarketBeat

Supernus Pharmaceuticals (NASDAQ:SUPN) Hits New 12-Month High – Here’s What Happened